Table 3 Disease management immediately following failure of the first platinum-based chemotherapy regimen

Initial platinum-based chemotherapy n, (%)

Neo/adjuvant setting, n = 76

Advanced setting, n = 137

 Cisplatin-based

50 (66 %)

71 (52 %)

 Carboplatin-based

26 (34 %)

66 (48 %)

Subsequent chemotherapy n, (%)

58 (76 %)

114 (83 %)

 Single agent

23

80

  Vinflunine/Taxanes

15/5

57/18

  Gemcitabine/Other agent

2/1

2/3

 Combination therapy

35

34

  cisplatin-based

11

5

  carboplatin-based

14

22

  Other

10

7

Subsequent management by BSC n, (%)

7 (9 %)

11 (8 %)

Pending decision or other^a n, (%)

11 (14 %)

12 (9 %)